Evidence map›Paper›PMID 16896225›Full record

ArticleEukaryotic cell2006

Membrane topology and transient acylation of Toxoplasma gondii glycosylphosphatidylinositols.

Jürgen Kimmel, Terry K Smith, Nahid Azzouz, Peter Gerold, Frank Seeber, Klaus Lingelbach, Jean-François Dubremetz, Ralph T Schwarz

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Jürgen KimmelInstitut für Virologie, Zentrum für Hygiene und Medizinische Mikrobiologie, Philipps-Universität, Robert-Koch-Strasse 17, 35037 Marburg, Germany.
Terry K Smith
Nahid Azzouz
Peter Gerold
Frank Seeber
Klaus Lingelbach
Jean-François Dubremetz
Ralph T Schwarz
Philipps University of Marburg · DEUnité de Glycobiologie Structurale et Fonctionnelle · FRUniversité de Montpellier · FRWellcome Trust · GB

Funding

Wellcome Trust 067441
6 · The paper itself

Abstract

Using hypotonically permeabilized Toxoplasma gondii tachyzoites, we investigated the topology of the free glycosylphosphatidylinositols (GPIs) within the endoplasmic reticulum (ER) membrane. The morphology and permeability of parasites were checked by electron microscopy and release of a cytosolic protein. The membrane integrity of organelles (ER and rhoptries) was checked by protease protection assays. In initial experiments, GPI biosynthetic intermediates were labeled with UDP-[6-(3)H]GlcNAc in permeabilized parasites, and the transmembrane distribution of the radiolabeled lipids was probed with phosphatidylinositol-specific phospholipase C (PI-PLC). A new early intermediate with an acyl modification on the inositol was identified, indicating that inositol acylation also occurs in T. gondii. A significant portion of the early GPI intermediates (GlcN-PI and GlcNAc-PI) could be hydrolyzed following PI-PLC treatment, indicating that these glycolipids are predominantly present in the cytoplasmic leaflet of the ER. Permeabilized T. gondii parasites labeled with either GDP-[2-(3)H]mannose or UDP-[6-(3)H]glucose showed that the more mannosylated and side chain (Glc-GalNAc)-modified GPI intermediates are also preferentially localized in the cytoplasmic leaflet of the ER.

Indexed as

AcylationAnimalsCarbohydrate SequenceCell MembraneCell Membrane PermeabilityEndoplasmic ReticulumGlycosylphosphatidylinositolsMolecular Sequence DataToxoplasmaGlycosylphosphatidylinositols

Identifiers

PMID16896225
PMCPMC1539143
OpenAlexW2129981643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.